Biochem Biophys Res Commun. 2001;280:1015–20.PubMedCrossRef 9. Canada-USA (CANUSA) peritoneal dialysis study group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol. 1996;7:198–207. 10. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33:27–39.PubMed 11. Yamazaki Y, Imura A, Urakawa I,

Shimada T, Murakami J, Aono Y, et al. Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun. 2010;398:513–8.PubMedCrossRef 12. Akimoto T, Liapis H, Hammerman MR. Microvessel formation from mouse embryonic aortic

explants is oxygen and VEGF dependent. Am J Physiol Regul Integr Comp Physiol. Bortezomib molecular weight 2002;283:R487–95.PubMed 13. van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal PXD101 function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1996;7:745–50.PubMed 14. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556–64.PubMed 15. Feinfeld DA, Danovitch GM. Factors affecting urine volume in chronic renal failure. Am J Kidney Dis. 1987;10:231–5.PubMed 16. Sotrastaurin mw Levey AS, Madaio MP, Perrone RD. Laboratory assessment of renal disease: clearance, urinalysis,

and renal biopsy. In: Brenner BM, Rector FC, editors. The kidney. 4th ed. Philadelphia: WB Saunders; Vorinostat 1991. p. 919–68. 17. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002;62:2223–9.PubMedCrossRef 18. Akimoto T, Ito C, Kato M, Ogura M, Muto S, Kusano E. Reduced hydration status characterized by disproportionate elevation of blood urea nitrogen to serum creatinine among the patients with cerebral infarction. Med Hypotheses. 2011;77:601–4.PubMedCrossRef 19. Blake PG. Integrated end-stage renal disease care: the role of peritoneal dialysis. Nephrol Dial Transplant. 2001;16(Suppl 5):61–6.PubMedCrossRef 20. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW. NECOSAD Study Group. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046–53.PubMedCrossRef 21. Lindholm B, Bergström J. Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol. 1988;30(Suppl 1):S59–63.PubMed 22. Bergström J, Fürst P, Alvestrand A, Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int. 1993;44:1048–57.PubMedCrossRef 23. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, et al. Protein losses during peritoneal dialysis.